You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ABT-530

Showing 26 - 50 of 393
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ulcerative Colitis (UC) Trial in Worldwide (Placebo, Upadacitinib)

Completed
Has Results
  • Ulcerative Colitis (UC)
  • Birmingham, Alabama
  • +495 more
Jun 3, 2022

Spinal Cord Injuries, Neurogenic Bladder, Neurogenic Bowel Trial in Vancouver (Transcutaneous Spinal Cord Stimulation, SHAM

Recruiting
  • Spinal Cord Injuries
  • +2 more
  • Transcutaneous Spinal Cord Stimulation
  • +2 more
  • Vancouver, British Columbia, Canada
    Blusson Spinal Cord Centre
Nov 21, 2022

Chronic Spontaneous Urticaria Trial in Dublin (ABT Online Programme, Delayed Control group)

Suspended
  • Chronic Spontaneous Urticaria
  • ABT Online Programme
  • Delayed Control group
  • Dublin, Ireland
    St James's Hospital
Oct 25, 2023

Chronic Lymphocytic Leucemia Trial in Cologne (Bendamustine, GA101, ABT-199)

Active, not recruiting
  • Chronic Lymphocytic Leucemia
  • Cologne, Germany
    German CLL Study Group
Sep 14, 2022

Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)

Active, not recruiting
  • Breast Cancer
  • +3 more
  • Boston, Massachusetts
  • +2 more
Dec 21, 2022

Chronic Lymphocytic Leukemia Trial in Worldwide (ABT-263)

Completed
  • Chronic Lymphocytic Leukemia
  • La Jolla, California
  • +9 more
Jul 8, 2022

Osteoarthritis of Hip Trial in Oswestry (Bioguard Group, Control Group)

Active, not recruiting
  • Osteoarthritis of Hip
  • Bioguard Group
  • Control Group
  • Oswestry, United Kingdom
    RJAH
Jan 24, 2023

Small Lymphocytic Lymphoma, Chronic Lymphocytic Leukemia Trial in Australia, United States (ABT-199, Rituximab)

Completed
  • Small Lymphocytic Lymphoma
  • Chronic Lymphocytic Leukemia
  • La Jolla, California
  • +5 more
Jul 11, 2022

Rheumatoid Arthritis Trial in Worldwide (Placebo for Adalimumab, Adalimumab, Placebo for Upadacitinib)

Active, not recruiting
Has Results
  • Rheumatoid Arthritis
  • Placebo for Adalimumab
  • +3 more
  • Birmingham, Alabama
  • +369 more
Jun 14, 2022

Crohn's Disease (CD) Trial in Worldwide (ABT-494)

Active, not recruiting
  • Crohn's Disease (CD)
  • La Jolla, California
  • +60 more
Sep 8, 2022

Hepatocellular Carcinoma, Cirrhosis Trial in Vandoeuvre-lès-Nancy ("Epi proColon 2.0 CE" test from Epigenomics, Inc (Berlin,

Recruiting
  • Hepatocellular Carcinoma
  • Cirrhosis
  • "Epi proColon 2.0 CE" test from Epigenomics, Inc (Berlin, Germany)
  • Vandoeuvre-lès-Nancy, France
    University Hospital of Nancy (CHRU de Nancy)
Jun 8, 2022

Chronic Hepatitis C, Hepatitis C Virus Trial (ABT-450/ritonavir (r), ABT-530, Ribavirin (RBV))

Completed
Has Results
  • Chronic Hepatitis C
  • Hepatitis C Virus
  • ABT-450/ritonavir (r)
  • +2 more
  • (no location specified)
Jan 25, 2018

Small Cell Lung Cancer Trial in Worldwide (Veliparib, Carboplatin, Etoposide)

Completed
Has Results
  • Small Cell Lung Cancer
  • Scottsdale, Arizona
  • +61 more
May 4, 2020

Crohn's Disease Trial in Worldwide (Upadacitinib, Placebo for Upadacitinib)

Completed
  • Crohn's Disease
  • Mobile, Alabama
  • +431 more
Feb 3, 2022

Psoriatic Arthritis Trial in Worldwide (Adalimumab, Upadacitinib, Placebo to Upadacitinib)

Active, not recruiting
Has Results
  • Psoriatic Arthritis
  • Huntsville, Alabama
  • +344 more
Dec 27, 2021

Chronic Lymphoid Leukemia Trial in Germany (Bendamustine, Obinutuzumab, Acalabrutinib)

Active, not recruiting
  • Chronic Lymphoid Leukemia
  • Dresden, Germany
  • +16 more
Nov 8, 2022

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • ABT-450/r/ABT-267, ABT-333
  • +4 more
  • (no location specified)
Jul 29, 2021

Hidradenitis Suppurativa Trial in Worldwide (Lutikizumab, Placebo)

Recruiting
  • Hidradenitis Suppurativa
  • Lutikizumab
  • Placebo
  • Phoenix, Arizona
  • +54 more
Jan 26, 2023

Endometriosis, Moderate to Severe Endometriosis-associated Pain Trial (BG2109 100mg, BG2109 200mg, ABT(E2 1 mg / NETA 0.5 mg))

Not yet recruiting
  • Endometriosis
  • Moderate to Severe Endometriosis-associated Pain
  • BG2109 100mg
  • +5 more
  • (no location specified)
Jun 6, 2023

Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

Completed
Has Results
  • Chronic Hepatitis C Infection
  • Compensated Cirrhosis
  • ABT-450/r/ABT-267, ABT-333
  • Ribavirin (RBV)
  • (no location specified)
Jul 8, 2021

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for Ribavirin)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • ABT-450/r/ABT-267, ABT-333
  • +2 more
  • (no location specified)
Jul 8, 2021

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ribavirin)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • ABT-450/r/ABT-267, ABT-333
  • +2 more
  • (no location specified)
Jul 8, 2021

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • (no location specified)
Jul 8, 2021

Moderate to Severe Secondary Hyperparathyroidism, Stage 5 Chronic Kidney Diseases Trial (Paricalcitol, Darbepoetin alfa)

Completed
Has Results
  • Moderate to Severe Secondary Hyperparathyroidism
  • Stage 5 Chronic Kidney Diseases
  • (no location specified)
Jul 28, 2021

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • ABT-450/r/ABT-267, ABT-333
  • +4 more
  • (no location specified)
Jul 8, 2021